Search
Searching Content indexed under Advertising, Marketing & Branding by Chiang Ling Li ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
First Financial Penalty Decision By The French ANSM
On May 19, 2016, the French National Drug and Health Product Authority ("ANSM") posted on its website its first two financial penalty decisions, adopted on May 12, 2016.
France
22 Jul 2016
2
FDA Announces Submission To OMB Of Information Collection On Quantitative Information In Direct-To-Consumer Television Advertisements
In the March 18, 2016, Federal Register, FDA announced that a proposed collection of information was submitted to the OMB, titled "Quantitative Information in Direct-to-Consumer Television Advertisements."
United States
13 Apr 2016
3
AMA Proposes Ban On Advertising Prescription Medical Products To Consumers
On November 17, 2015, physicians at the Interim Meeting of the American Medical Association ("AMA") adopted a new policy calling for a ban on DTC advertising of prescription drugs and medical devices.
United States
23 Nov 2015
4
OPDP Warning Letter Targets Social Media Campaign
FDA's Office of Prescription Drug Promotion ("OPDP") issued two warning letters regarding pharmaceutical product promotion in a two-week timeframe, most recently citing social media posts.
United States
18 Aug 2015
5
District Court Rules Against FDA In Off-Label Marketing Case
Last week, a federal judge in the Southern District of New York granted a preliminary injunction in favor of Amarin Pharma, Inc. ("Amarin") in its dispute against FDA asserting free speech rights to promote an approved drug for unapproved uses based on truthful and nonmisleading communications
United States
17 Aug 2015
6
FDA Revises Draft Guidance On Drug Promotional Materials
FDA recently released updated draft guidance on how to explain risks to consumers in advertisements and labeling for prescription drugs, particularly the "consumer brief summary."
United States
16 Feb 2015
7
White House Regulatory Agenda Forecasts Drug And Device Regulations For 2015
The White House's most recent Unified Agenda outlines several major drug and device rules and proposed rules FDA intends to issue in the coming year.
United States
16 Jan 2015
Links to Result pages
 
1